Loading...
•
Sep 30, 2023
Bio-Techne Q1 2024 Earnings Report
Bio-Techne's first quarter results for fiscal year 2024 were released, showing revenue growth and strategic progress.
Key Takeaways
Bio-Techne reported a 3% increase in first-quarter revenue to $276.9 million, with organic revenue growth of 2%. GAAP EPS was $0.31, while adjusted EPS was $0.41. The company highlighted strong performance in EMEA and continued growth in key product lines.
First quarter organic revenue increased by 2% to $276.9 million.
GAAP EPS was $0.31, and adjusted EPS was $0.41.
ExoDx prostate test volume increased 49%, and GMP proteins revenue increased 39%.
EMEA region experienced organic growth of 15%.
Bio-Techne
Bio-Techne
Bio-Techne Revenue by Segment
Revenue by Segment
Protein Sciences Revenue
CapyFin.comDiagnostics & Spatial Bio Revenue
CapyFin.com Forward Guidance
No specific forward guidance was provided in the press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income